Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Best Buy Co Inc (BBY) vs Cronos Group Inc (CRON) Price & Performance

Best Buy Co IncTrade
Cronos Group IncTrade

Price performance (Past 24H)

Key statistics

Best Buy Co Inc vs Cronos Group Inc — how do they compare? Best Buy Co Inc trades at $83.5 (market cap $17.37B), while Cronos Group Inc trades at $3.08 (market cap $1.11B). The key difference: Best Buy Co Inc is far larger — about 15.6× Cronos Group Inc's market cap, and Best Buy Co Inc pays a 4.66% dividend while Cronos Group Inc pays none. Which is the better fit depends on your goals.

BBYCRON
Market Cap
$17.37B$1.11B
Sector
Consumer CyclicalHealth
52-Week High
$90.17$3.27
52-Week Low
$55.52$2.30
Enterprise Value
$19.75B$310.67M
Dividend Yield
4.66%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Best Buy Co Inc

With $51.8 billion in fiscal 2022 sales, Best Buy is the largest pure-play consumer electronics retailer in the U.S., with roughly 10.6% share of the aggregate market and north of 40% share of offline sales, per our calculations, CTA industry, and Euromonitor data. The firm generates the bulk of its sales in-store, with mobile phones and tablets, computers, and appliances representing its three largest categories. Recent investments in e-commerce fulfillment, accelerated by the COVID-19 pandemic, have seen the U.S. e-commerce channel roughly double from prepandemic levels, with management estimating that it will represent a mid-30% proportion of sales moving forward.

Read more on BBY

About Cronos Group Inc

Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.

Read more on CRON